H. Schoemans

发表

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

W. Wood, M. Aljurf, J. Szer, 2017, Cancer.

A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).

L. Michaux, P. Vandenberghe, H. Schoemans, 2014, Cancer genetics.

How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation

F. Baron, T. Kerre, H. Schoemans, 2020, Frontiers in Immunology.

Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013

K. Lagrou, J. Maertens, J. Wauters, 2014, Emerging infectious diseases.

eHealth generated patient data in an outpatient setting after stem cell transplantation: a scoping review.

A. Zhao, A. Sung, H. Schoemans, 2022, Transplantation and cellular therapy.

Current practice in vitamin D management in Allogeneic Haematopoietic Stem Cell Transplantation: a survey by the Transplant Complications Working Party of the EBMT.

J. Snowden, K. Peggs, D. Greenfield, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK

S. Constantinescu, J. Demoulin, R. Albu, 2011, Haematologica.

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

W. Wood, A. Gratwohl, M. Aljurf, 2020, Cancer.

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

P. Vermeersch, M. Hoenigl, P. Annaert, 2016, European Journal of Clinical Pharmacology.

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

J. Bourhis, N. Kröger, P. Chevallier, 2021, Frontiers in Immunology.

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

A. Nagler, M. Mohty, D. Niederwieser, 2014, Haematologica.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

I. Yakoub-Agha, D. Blaise, P. Rohrlich, 2018, Bone Marrow Transplantation.

Prevalence and Factors Associated with Marital Distress among Hematopoietic Cell Transplant Survivors: Results from a Large Cross-sectional Study.

S. Langer, Stephanie J. Lee, K. Syrjala, 2022, Transplantation and cellular therapy.

miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2

L. Michaux, P. Saussoy, J. Demoulin, 2020, Journal of cellular and molecular medicine.

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

M. Aljurf, G. Basak, N. Chaudhri, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis

G. Verleden, B. Weynand, S. Verleden, 2021, Frontiers in Immunology.

Sexual functioning in long-term survivors of hematopoietic cell transplantation.

S. Langer, Stephanie J. Lee, K. Syrjala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adult umbilical cord blood transplantation: a comprehensive review

J. Wagner, C. Verfaillie, M. Boogaerts, 2006, Bone Marrow Transplantation.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ETV6-PDGFRB and FIP1l1-PDGFRA stimulate human hematopoietic progenitor proliferation and differentiation into eosinophils via NF-kB

L. Knoops, J. Demoulin, A. Essaghir, 2011 .

ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κB

L. Knoops, J. Demoulin, A. Essaghir, 2012, Haematologica.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT Study

G. Basak, Z. Perić, H. Schoemans, 2020, Frontiers in Immunology.

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

H. Putter, N. Kröger, J. Finke, 2017, Bone Marrow Transplantation.

How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT.

S. Montoto, N. Kröger, I. Yakoub-Agha, 2020, Blood advances.

Bone healing with bortezomib-based regimens in multiple myeloma: a retrospective imaging study

A. Laenen, M. Delforge, D. Dierickx, 2014 .

Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party

A. Ganser, J. Sierra, H. Greinix, 2019, Haematologica.

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

E. Holler, H. Greinix, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept

F. Dobbels, S. Geest, H. Greinix, 2016, Bone Marrow Transplantation.

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

N. Kröger, A. Nagler, M. Mohty, 2020, The Lancet. Haematology.

Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?

H. Schoemans, B. Vanaudenaerde, R. Vos, 2022, The Lancet. Respiratory medicine.

Improving medication adherence: The proof of the pudding will be in the eating

F. Dobbels, H. Schoemans, J. Vanhoof, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial

Daniel Wolff, Steffen Fieuws, Carlos Graux, 2018, Haematologica.

Chronic gvhd dictionary—eurograft cost action initiative consensus report

H. Greinix, Stephanie J. Lee, D. Pulanić, 2022, Bone Marrow Transplantation.

Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress

F. Dobbels, H. Greinix, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

H. Greinix, Z. DeFilipp, D. Kelly, 2018, Bone Marrow Transplantation.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vaccination guidelines in hematopoietic transplant patients : recommendations from the BHS Transplant Committee

T. Kerre, H. Schoemans, Y. Beguin, 2014 .

Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity

K. Theunissen, K. Lagrou, W. Meersseman, 2012, Journal of Clinical Microbiology.

Salvage haploidentical or cord‐blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM‐TC

M. Robin, P. Chevallier, G. Guillerm, 2022, European journal of haematology.

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature

F. Baron, D. Deeren, T. Kerre, 2020, Acta clinica Belgica.

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

S. Montoto, N. Kröger, A. Nagler, 2018, Bone Marrow Transplantation.

Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT

D. Greenfield, J. Mooyaart, Z. Perić, 2022, Bone Marrow Transplantation.

A Systematic Review of Patient Reported Outcome Measures in Graft-versus-Host-Disease (GVHD).

R. Matin, H. Schoemans, E. Gibbons, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cryptococcal Disease and Endemic Mycosis

J. Maertens, H. Schoemans, 2011 .

Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012.

K. Lagrou, J. Maertens, H. Schoemans, 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Toxoplasmosis after allogeneic hematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach.

K. Lagrou, J. Maertens, H. Schoemans, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation–An Analysis of 2 German Transplantation Centers

E. Holler, M. Edinger, H. Schoemans, 2020, Frontiers in Public Health.

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

M. Norkin, W. Wood, J. Wingard, 2015, Bone Marrow Transplantation.

Management of growth failure and growth hormone deficiency after pediatric allogeneic HSCT: Endocrinologists are of importance for further guidelines and studies

A. Tichelli, G. Basak, C. Peters, 2019, Pediatric hematology and oncology.

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

A. Ganser, J. Sierra, H. Greinix, 2020, Frontiers in Immunology.

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

N. Kröger, S. Iacobelli, G. Gahrton, 2013, Bone Marrow Transplantation.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

Patient reported outcomes

H. Schoemans, 2021, Blood and Marrow Transplantation Long Term Management.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

G. Basak, I. Moiseev, Z. Perić, 2022, Bone Marrow Transplantation.

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

S. Montoto, P. Dreger, J. Passweg, 2019, Bone Marrow Transplantation.

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

M. Grce, H. Greinix, A. Barata, 2022, Bone Marrow Transplantation.

What do Patients Want? The Importance of Patient-reported Outcomes

H. Schoemans, N. Bolaños, L. Warwick, 2022, The EBMT/EHA CAR-T Cell Handbook.

A Conceptual Framework and Key Research Questions in Educational Needs of Blood and Marrow Transplantation Patients, Caregivers, and Families.

M. Bevans, B. Shaw, H. Schoemans, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

M. Norkin, A. Nagler, J. Szer, 2018, Bone Marrow Transplantation.

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

S. Montoto, S. Iacobelli, J. Sierra, 2022, Journal of clinical medicine.

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

W. Wiktor-Jedrzejczak, N. Kröger, M. Labopin, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

“This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany

E. Holler, A. Barata, J. Loss, 2021, Frontiers in Public Health.

ATG or no ATG? – survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT

G. Basak, I. Moiseev, A. Piekarska, 2022, Bone Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation

G. Verleden, B. Weynand, S. Verleden, 2019, Modern Pathology.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

N. Kröger, M. Labopin, A. Nagler, 2021, Bone Marrow Transplantation.

Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT

N. Kröger, C. Crawley, N. Russell, 2021, Bone Marrow Transplantation.

Pre-transplant marital status and hematopoietic cell transplantation outcomes.

W. Wood, K. Sullivan, M. Aljurf, 2020, Current oncology.

Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT

N. Kröger, I. Yakoub-Agha, M. Mohty, 2021, Bone Marrow Transplantation.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

One step at a time

P. Ljungman, H. Schoemans, 2021, Blood.